Pages
- @afrocab_hiv and #TAG are excited to share a call for a new cross-disease long-acting technologies (LAT) community advisory board (CAB) focused on #malaria, the #HepC virus and #LTBI for a 4year tenure, 2021-2024. Deadline 1st June 2021!
- About AfroCAB
- AfroCAB activities by country
- AfroCAB members
- AFROCAB members at INTEREST conference
- Afrocab Treatment Access Partnership
- AHD Graphics to share!
- Board Members
- Contact AfroCAB
- Join the AfroCAB
- Meetings
- Resources
Posts
- Category: ESC
- Category: Meetings
- [Extended] Call for applicants Adolescent, Pediatric and Adult Community Advisory Board (CAB) Member THRIVE AHD Project
- Call for applications Adolescent, Pediatric and Adult Community Advisory Board (CAB) Members THRIVE AHD Project
- Consultancy: Salary, Benefits and Remuneration Benchmarking
- Afrocab is recruiting!
- Dolutegravir-Based ART — Effective for HIV-2 Infection
- Open Letter: Community Statement on Accelerating Access to Lenacapavir by Gilead
- CALL FOR APPLICATIONS SMART4TB CAB MEMBERSHIP 2023-2027
- AFROCAB COMMUNITY FORUM: Supporting Affordable Access to Long-Acting Technologies; the Future of HIV Prevention and Treatment
- An Open Letter to WHO on access to DRV/r 400/50 mg in LMICs
- Darunavir/ritonavir (DRV/r) Advocacy!
- World AIDS Day Community Statement!
- CAB-LA in the News- Special Edition!
- CAB- LA in the News!
- CAB LA in The News!
- CAB LA in the News!
- CAB LA in The News!
- CAB-LA in the news
- CAB- LA in the news!
- CAB LA Community Forum Statement
- Open Letter to Ambassador John Nkengasong as PEPFAR Global Coordinator
- Afrocab Update on CAB-LA Progress
- ViiV continues to not meet our demands to ensure CAB-LA is accessible for our communities
- Communities demand ViiV/GSK accelerate access to CAB-LA in LMICs
- Upcoming Community Forum on Thursday, Feb 17 - Access to Long-Acting HIV Prevention Products
- Community Position Statement: DRV/r Must Urgently Become the Preferred Protease Inhibitor Used in Adult Second-Line ART
- Recording & Resources: AfroCAB COVID -19 Therapeutics Workshop -2020
- Enabling Access to Treatment Monitoring During the Pandemic. Please see our AfroCAB/CHAI Community Webinar Series Brief held Thursday, June 25th.
- AfroCAB/CHAI Community Webinar Series: JOIN US ON THURSDAY, 25th June 2020
- AFROCAB DTG_Weight Gain_ Hyperglycemia Meeting Communiqué
- AFROCAB at IAS 2019
- CHAI-Unitaid Optimal Community Advisory Board Quarterly Newsletter
- Communique of the Kigali Dolutegravir Stakeholder Meeting of African Women Living with HIV, hosted by AfroCAB
- Paris (IAS) treatment optimisation meeting
- CHAI-CAB Dakar: 11-12 April 2017
- New pDTG Resources to Share!
- CHAI CAB
- INTEREST workshop, Yaounde Cameroon
- Rwanda
- Rwanda
- Zimbabwe
- Zambia
- Kenya
- Swaziland
- contact form
- Category: Meeting Reports
- Recording & Resources: AfroCAB COVID -19 Therapeutics Workshop -2020
- Enabling Access to Treatment Monitoring During the Pandemic. Please see our AfroCAB/CHAI Community Webinar Series Brief held Thursday, June 25th.
- Communique of the Kigali Dolutegravir Stakeholder Meeting of African Women Living with HIV, hosted by AfroCAB
- Paris (IAS) treatment optimisation meeting
- CHAI-CAB Dakar: 11-12 April 2017
- New pDTG Resources to Share!
- CHAI CAB
- Rwanda
- Zimbabwe
- Zambia
- Kenya
- Swaziland
- Category: News
- Category: Presentations
- New pDTG Resources to Share!
- Recording & Resources: AfroCAB COVID -19 Therapeutics Workshop -2020
- Communique of the Kigali Dolutegravir Stakeholder Meeting of African Women Living with HIV, hosted by AfroCAB
- Paris (IAS) treatment optimisation meeting
- New pDTG Resources to Share!
- CHAI CAB
- INTEREST workshop, Yaounde Cameroon
- Rwanda
- Rwanda
- Zimbabwe
- Zambia
- Swaziland
- Category: Reports
- Category: Uncategorized
Plugin by dagondesign.com